SciVac's Reverse Merger Round

SciVac raised a round of funding on March 20, 2015. Investors include Levon Resources.

SciVac is in the business of developing, producing and marketing biological products for human healthcare. SciVac's flagship product Sci-B-Vac is a recombinant 3rd generation hepatitis B vaccine. SciV…

Articles about SciVac's Reverse Merger Round: